Numinus Wellness (TSE:NUMI) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Numinus Wellness is set to acquire MedBright AI, with plans to rebrand as Numinus Intelligence and integrate AI into enhancing mental health treatments across the U.S. This strategic move aims to merge MedBright’s AI capabilities with Numinus’s expertise in drug-assisted therapy to improve clinic operations and boost revenue. The acquisition is expected to strengthen Numinus’s balance sheet and advance its goal of achieving positive EBITDA.
For further insights into TSE:NUMI stock, check out TipRanks’ Stock Analysis page.
